DekaBank Deutsche Girozentrale’s Sana Biotechnology SANA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-112,300	Closed	-$1.22M	–	1316
2025 Q4	$1.22M	Hold	112,300	–	–	﹤0.01%	840
2025 Q3	$1.21M	Hold	112,300	–	–	﹤0.01%	839
2025 Q2	$1.22M	Hold	112,300	–	–	﹤0.01%	825
2025 Q1	$1.12M	Hold	112,300	–	–	﹤0.01%	827
2024 Q4	$1.06M	Hold	112,300	–	–	﹤0.01%	866
2024 Q3	$1.12M	Hold	112,300	–	–	﹤0.01%	863
2024 Q2	$1.12M	Hold	112,300	–	–	﹤0.01%	854
2024 Q1	$1.12M	Hold	112,300	–	–	﹤0.01%	850
2023 Q4	$489K	Hold	112,300	–	–	﹤0.01%	1041
2023 Q3	$448K	Hold	112,300	–	–	﹤0.01%	1040
2023 Q2	$663K	Hold	112,300	–	–	﹤0.01%	971
2023 Q1	$349K	Hold	112,300	–	–	﹤0.01%	1089
2022 Q4	$426K	Hold	112,300	–	–	﹤0.01%	1072
2022 Q3	$633K	Hold	112,300	–	–	﹤0.01%	995
2022 Q2	$702K	Hold	112,300	–	–	﹤0.01%	957
2022 Q1	$915K	Buy	112,300 +10,200	+10%	+$82.5K	﹤0.01%	924
2021 Q4	$1.57M	Buy	102,100 +85,500	+515%	+$1.65M	﹤0.01%	828
2021 Q3	$358K	Buy	16,600 +15,000	+938%	+$315K	﹤0.01%	1115
2021 Q2	$29K	Buy	+1,600	New	+$36.3K	﹤0.01%	1363

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SANA Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 112,300 shares — an estimated $1.22M sold.

DekaBank Deutsche Girozentrale first reported a position in SANA in Q2 2021 and held it in 19 quarters. The position peaked at $1.57M in Q4 2021. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 112,300 Sana Biotechnology shares in Q1 2026, an estimated $1.22M.
DekaBank Deutsche Girozentrale first reported a position in Sana Biotechnology in Q2 2021 and held it in 19 quarters.
DekaBank Deutsche Girozentrale's Sana Biotechnology position peaked at $1.57M in Q4 2021.
203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.